- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
5
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
5 companies
Searle
Market Cap: PK₨64.9b
Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.
SEARL
PK₨110.27
7D
2.9%
1Y
79.9%
Highnoon Laboratories
Market Cap: PK₨58.6b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨1,105.98
7D
-2.1%
1Y
30.8%
Hoechst Pakistan
Market Cap: PK₨40.5b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,200.00
7D
2.1%
1Y
74.9%
Abbott Laboratories (Pakistan)
Market Cap: PK₨107.6b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,098.92
7D
-0.07%
1Y
22.1%
GlaxoSmithKline Pakistan
Market Cap: PK₨123.8b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨388.65
7D
-1.4%
1Y
36.5%